Verona Pharma Posts Q1 Operating Expenses $86.573 Mln

Reuters
29 Apr
April 29 (Reuters) - Verona Pharma PLC ::
*VERONA PHARMA Q1 OPERATING EXPENSES USD 86.573 MILLION
*VERONA PHARMA Q1 PRETAX PROFIT USD -16.558 MILLION VERSUS. IBES ESTIMATE USD -17.4 MILLION
*VERONA PHARMA Q1 OPERATING INCOME USD -10.317 MILLION VERSUS. IBES ESTIMATE USD -13.6 MILLION
*VERONA PHARMA Q1 BASIC EPS USD -0.02
*VERONA PHARMA Q1 NET INCOME USD -16.319 MILLION VERSUS. IBES ESTIMATE USD -16.1 MILLION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 29-APR-202510:00:00.2 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10